|
業務類別
|
Biotechnology |
|
業務概覽
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
| 公司地址
| 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, USA, 94005 |
| 電話號碼
| +1 650 770-0077 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.veratx.com |
| 員工數量
| 249 |
| Dr. Robert M. Brenner,M.D. |
Chief Medical Officer |
美元 476.62K |
03/04/2025 |
| Mr. William D. Turner |
Chief Development Officer |
-- |
03/04/2025 |
| Ms. Lauren Frenz |
Chief Business Officer |
-- |
03/04/2025 |
| Mr. David L. Johnson, M.D. |
Chief Operating Officer |
-- |
03/04/2025 |
| Dr. Marshall Fordyce, M.D. |
President, Chief Executive Officer and Director |
美元 616.25K |
26/02/2026 |
| Mr. Joseph Young |
Senior Vice President, Finance and Chief Accounting Officer |
-- |
26/02/2026 |
| Mr. Sean P. Grant |
Chief Financial Officer |
-- |
26/02/2026 |
|
|
| Dr. Beth C. Seidenberg,M.D. |
Independent Director |
26/02/2026 |
| Mr. Patrick G. Enright, M.B.A. |
Independent Director |
26/02/2026 |
| Mr. James R. Meyers |
Director |
26/02/2026 |
| Mr. Christopher Hite |
Director |
09/03/2026 |
| Dr. Michael M. Morrissey, PhD |
Chairman of the Board |
26/02/2026 |
| Mr. Scott William Morrison |
Independent Director |
26/02/2026 |
| Dr. Maha Katabi, PhD |
Independent Director |
26/02/2026 |
| Dr. Andrew Cheng, M.D.,PhD |
Independent Director |
26/02/2026 |
| Dr. Marshall Fordyce, M.D. |
President, Chief Executive Officer and Director |
26/02/2026 |
| Ms. Christy J. Oliger |
Independent Director |
26/02/2026 |
| Ms. Kimball Hall |
Independent Director |
26/02/2026 |
|
|
|
|
